Protecting Patient Access to Lifesaving COVID–19 Drugs Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 25, 2021)
Protecting Patient Access to Lifesaving COVID-19 Drugs Act of 2021
This bill requires health insurance plans to cover COVID-19 (i.e., coronavirus disease 2019) antibody treatment at no cost for individuals who have tested positive for the virus.
What just happenedFeb 2, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJan 25, 2021
- Feb 2, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 25, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Education and the Workforce Committee - Jan 25, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jan 25, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jan 25, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 25, 2021IntroReferralIntro-H
Introduced in House
- Jan 25, 2021IntroReferral1000
Introduced in House